[From gene defect to drug therapy for obesity?].
Grünewald-Funk
Dorle
D
D002648:Child; D004734:Energy Metabolism / Q000502:physiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D020738:Leptin / Q000502:physiology; D009074:Melanocyte-Stimulating Hormones / Q000502:physiology; D009765:Obesity / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D011333:Pro-Opiomelanocortin / Q000235:genetics / Q000502:physiology; D044105:Receptor, Melanocortin, Type 4; D018043:Receptors, Corticotropin / Q000819:agonists* / Q000235:genetics / Q000378:metabolism
D020738:Leptin; D044105:Receptor, Melanocortin, Type 4; D018043:Receptors, Corticotropin; D011333:Pro-Opiomelanocortin; D009074:Melanocyte-Stimulating Hormones